Then, we detected the strongly positive staining of HSDL2 in both the samples of late stage (Figure 1F) and lymph node metastasis (Figure 1G), the rates were respectively 61.2% (21/119) and 39.7% (57/119). This evidence concerns the gene HSDL2 and metastatic malignant neoplasm in the lymph nodes.